Plant Comparison
Field Horsetail vs Perforate St John’s-wort
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Field Horsetail and Perforate St John’s-wort: they share 6 indicated uses (arthritis / joint pain, bruising, infection (general), …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Field Horsetail | Perforate St John’s-wort | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 5/10 | 1/10 | Stronger for Field Horsetail |
| Bruising | 5/10 | 1/10 | Stronger for Field Horsetail |
| Infection (general) | 5/10 | 1/10 | Stronger for Field Horsetail |
| Inflammation (general) | 5/10 | 1/10 | Stronger for Field Horsetail |
| Skin irritation | 5/10 | 1/10 | Stronger for Field Horsetail |
| Wounds | 5/10 | 1/10 | Stronger for Field Horsetail |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Field horsetail is exceptionally rich in silica, concentrated in the stem, and is a signature source of this mineral in Western herbal medicine.
Antioxidant flavonoids contributing to the plant's anti-inflammatory activity.
An enzyme that degrades vitamin B1 (thiamine); the basis of the caution against prolonged or excessive use.
Red pigments historically used to standardise extracts; contribute to antiviral activity and are the compounds responsible for photosensitivity risk.
Considered the principal compound behind the antidepressant activity and the main driver of the herb's potent CYP3A4/P-glycoprotein induction and drug-interaction profile.
Antioxidant flavonoids contributing to overall activity.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anti-rheumatic action
inferred from anticancer action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from diuretic action
inferred from diuretic action
inferred from diuretic action
inferred from anti-inflammatory action
inferred from antiviral action
inferred from anti-inflammatory action
inferred from sedative action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Field horsetail contains thiaminase, an enzyme that degrades thiamine (vitamin B1); prolonged or excessive use can cause thiamine deficiency — symptoms include neurological problems and weight loss. This risk is greatest with repeated large doses or prolonged use. The plant also contains nicotine at low levels and silica compounds. Not recommended for children or during pregnancy and breastfeeding. People with impaired kidney function should avoid use, as diuretic effects may worsen fluid and electrolyte imbalance. Caution with concurrent diuretic medications. The EMA herbal monograph recognises traditional use at appropriate short-term doses in adults only (European Medicines Agency, 2016; Sandhu et al., 2010).
Duke (2002) rates horsetail as + (moderate caution) and notes clinical evidence (score 2) for its diuretic and wound-healing (vulnerary) activities, consistent with Commission E approval. High silica content may strengthen connective tissue, hair, and nails. Dose: 6 g dried herb daily as tea or in capsules. Horsetail contains thiaminase (breaks down vitamin B1) and an unidentified neurotoxin — it should not be taken long-term or in large quantities. Not for use in patients with edema due to cardiac or renal insufficiency, and avoid in children under 12 (Duke, 2002).
Significant drug interactions: strongly induces CYP3A4 and P-glycoprotein, reducing plasma levels of many drugs including oral contraceptives, antiretrovirals, cyclosporine, warfarin, and digoxin. May cause photosensitivity (fair-skinned individuals). Do not combine with SSRIs, SNRIs, or MAOIs (serotonin syndrome risk). Avoid in bipolar disorder.
Duke (2002) rates St. John's wort as ++ (raised from earlier editions) and notes antidepressant, antiviral, antibacterial, and wound-healing activities at experimental and clinical levels. Hypericin and hyperforin are identified as key active constituents. Clinical evidence (score 2) confirms antidepressant efficacy in mild-to-moderate depression, and WHO/Commission E provide approval for this indication. Dose: 300 mg standardized extract (0.3% hypericin, 3–5% hyperforin) three times daily. Duke emphasizes the critical drug interaction: St. John's wort is a potent CYP3A4 inducer and can significantly reduce blood levels of many medications including oral contraceptives, cyclosporine, antiretrovirals, and warfarin. Avoid combined use with SSRIs (serotonin syndrome risk) and pharmaceutical antidepressants (Duke, 2002).
External Ids
Botanical Description
Perennial, spore-bearing (non-flowering) plant with two distinct stem types arising from a deep, black, jointed rhizome. In early spring, unbranched, pale brownish fertile stems appear first, each topped with a spore-bearing cone, and die back once spores are shed; these are followed by the familiar green, hollow, jointed, ridged sterile stems bearing whorls of thin, needle-like branches at each node, giving a bottlebrush appearance.
Erect, branching perennial herb with paired, oval leaves dotted with tiny translucent oil glands that look like pinpricks when held to the light (giving the species name 'perforatum'). Bright yellow, five-petalled flowers with numerous stamens and black dots along the petal edges are borne in flat-topped clusters, and release a reddish pigment when crushed.[4]
Habitat
Grows in damp grassland, waste ground, riverbanks, roadsides and disturbed soil on a wide range of soils; native and common across the temperate Northern Hemisphere (Europe, Asia, North America).
Grows in grassland, roadsides, woodland clearings and waste ground on well-drained soils; native to Europe, Western Asia and North Africa and widely naturalised elsewhere, including North America and Australia.[4]
Harvesting
The green sterile stems are cut in summer, at their most vigorous, and dried quickly in a warm, shaded, airy place; careful identification against the more toxic marsh horsetail (Equisetum palustre), which grows in similar damp ground, is essential before wild-harvesting.
The flowering tops (flower and upper leaf) are cut in summer as the flowers open, around the traditional St John's Day period, and dried quickly in a warm, shaded, airy place to preserve the hypericin and hyperforin content.[4]
Traditional Uses
Field horsetail has a long European folk history as a diuretic remedy for urinary gravel and mild fluid retention, as an astringent, anti-inflammatory and vulnerary herb for wounds and connective-tissue support, and, owing to its very high silica content, as a traditional tonic for hair, nails and skin.[11]
St John's wort has a centuries-long European folk reputation as a wound-healing and nerve tonic herb, traditionally used for mild wounds, burns and nerve pain and to lift low mood; this traditional mood-supporting use is now one of the most extensively clinically studied applications of any herbal medicine, with standardised extracts shown comparable to conventional antidepressants for mild-to-moderate depression.[1, 4]
Preparations
Dried sterile stem simmered or infused in hot water as a traditional diuretic and connective-tissue-support tea.
Flowering-top extract standardised to hypericin and/or hyperforin content, taken as tablets or capsules; the best-studied clinical form for mood support.
Dosage
The EU herbal monograph gives a single dose of 1-4 g of the comminuted herb in 150 mL of boiling water as an infusion or decoction (5-15 minutes), 3-4 times daily, for a daily dose of 3-12 g, in adolescents, adults and elderly; traditionally used over a period of 2 to 4 weeks. For cutaneous use, 10 g in 1 L of water as a decoction for impregnated dressings and irrigation. Not recommended under 12 years. Educational reference only, not a prescription.
Clinical trials for mild-to-moderate depression commonly use around 300 mg of standardised extract three times daily (900 mg/day total); given extensive drug interactions, use should be discussed with a healthcare provider, especially alongside other medicines. Educational reference only, not a prescription.
References
Lookalikes Review
Dangerous Lookalikes
Not documented
Drug Class Interactions
Not documented
Pairings
Not documented
St John's wort raises serotonin activity and can cause serotonin syndrome when combined with other serotonin-boosting agents; pairing it with another mood-active, serotonergic herb such as saffron may add to this risk.[30]
St John's wort is a strong enzyme inducer and increases serotonin activity; combining it with another antidepressant-type herb such as rhodiola may add to serotonergic effects and unpredictably change how each is handled by the body.[30]
St John's wort speeds up the breakdown of many substances and also raises serotonin activity; pairing it with a sedative herb such as valerian may add to drowsiness and can unpredictably change how each is handled by the body.[30, 31]
St John's wort is a strong enzyme inducer and kava is a liver-metabolised sedative; combining them may add to central-nervous-system effects and alter how kava is processed, so combined use warrants caution.[30, 31]
References & Sources
- Hegedus, C., Muresan, M., Badale, A., Bombicz, M. and others (2020) 'SIRT1 Activation by Equisetum arvense L. (Horsetail) Modulates Insulin Sensitivity in Streptozotocin Induced Diabetic Rats', Molecules, 25(11), pp. 2541. doi:10.3390/molecules25112541 Preclinical
https://doi.org/10.3390/molecules25112541 - Dragos, D., Gilca, M., Gaman, L., Vlad, A., Iosif, L. et al (2017) 'Phytomedicine in Joint Disorders', Nutrients, 9(1), pp. 70. doi:10.3390/nu9010070 Traditional / reference
https://doi.org/10.3390/nu9010070 - Grundemann, C., Lengen, K., Sauer, B., Garcia-Kaufer, M. and others (2014) 'Equisetum arvense (common horsetail) modulates the function of inflammatory immunocompetent cells', BMC Complementary and Alternative Medicine, 14, pp. 283. doi:10.1186/1472-6882-14-283 Preclinical
https://doi.org/10.1186/1472-6882-14-283 - Wang, L., Zhang, L., Zheng, G. and Luo, H (2021) 'Equisetum arvense L aqueous extract: a novel chemotherapeutic supplement for treatment of human colon carcinoma', Archives of Medical Science, 19(5), pp. 1472-1478. doi:10.5114/aoms/138146 Preclinical
https://doi.org/10.5114/aoms/138146 - Jeong, S.Y., Yu, H.S., Ra, M.J., Jung, S.M. and others (2023) 'Phytochemical Investigation of Equisetum arvense and Evaluation of Their Anti-Inflammatory Potential in TNFalpha/INFgamma-Stimulated Keratinocytes', Pharmaceuticals, 16(10), pp. 1478. doi:10.3390/ph16101478 Preclinical
https://doi.org/10.3390/ph16101478 - Klncalp, S., Ekiz, F., Basar, O., Coban, S. and others (2012) 'Equisetum arvense (Field Horsetail)-induced liver injury', European Journal of Gastroenterology & Hepatology, 24(2), pp. 213-214. doi:10.1097/MEG.0b013e32834e7ff0 Preclinical
https://doi.org/10.1097/MEG.0b013e32834e7ff0 - Maeda, H., Miyamoto, K. and Sano, T (1997) 'Occurrence of dermatitis in rats fed a cholesterol diet containing field horsetail (Equisetum arvense L.)', Journal of Nutritional Science and Vitaminology, 43(5), pp. 553-563. doi:10.3177/jnsv.43.553 Preclinical
https://doi.org/10.3177/jnsv.43.553 - Saslis-Lagoudakis, C.H., Bruun-Lund, S., Iwanycki, N.E., Seberg, O. and others (2015) 'Identification of common horsetail (Equisetum arvense L.; Equisetaceae) using Thin Layer Chromatography versus DNA barcoding', Scientific Reports, 5, pp. 11942. doi:10.1038/srep11942 Preclinical
https://doi.org/10.1038/srep11942 - Mimica-Dukic, N., Simin, N., Cvejic, J., Jovin, E. and others (2008) 'Phenolic compounds in field horsetail (Equisetum arvense L.) as natural antioxidants', Molecules, 13(7), pp. 1455-1464. doi:10.3390/molecules13071455 Preclinical
https://doi.org/10.3390/molecules13071455 - Tufarelli, V., Baghban-Kanani, P., Azimi-Youvalari, S., Hosseintabar-Ghasemabad, B. and others (2021) 'Effects of Horsetail (Equisetum arvense) and Spirulina (Spirulina platensis) Dietary Supplementation on Laying Hens Productivity and Oxidative Status', Animals, 11(2), pp. 335. doi:10.3390/ani11020335 Preclinical
https://doi.org/10.3390/ani11020335 - Carneiro, D.M., Marques, L.C., Velasques, L.O. et al (2016) 'Randomized, double-blind clinical trial to assess the acute diuretic effect of Equisetum arvense (Field Horsetail) in healthy volunteers'. doi:10.1155/2014/760683 Randomized trial
https://doi.org/10.1155/2014/760683 - European Medicines Agency (2016) 'European Union herbal monograph on Equisetum arvense L., herba'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-equisetum-arvense-l-herba_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-equisetum-arvense-l-herba_en.pdf - http://LatvijasDaba.lv (n.d.) 'tīruma kosa – Equisetum arvense L'. Available at: http://LatvijasDaba.lv Traditional / reference
http://LatvijasDaba.lv - Royal Botanic Gardens, Kew (n.d.) 'Equisetum arvense L'. Available at: https://powo.science.kew.org/taxon/urn:lsid:http://ipni.org:names:17003330-1 Traditional / reference
https://powo.science.kew.org/taxon/urn:lsid:http://ipni.org:names:17003330-1 - Sandhu, N.S., Kaur, S. and Chopra, D (2010) 'Equisetum arvense: pharmacology and phytochemistry — a review', 3(3), pp. 146--150. Traditional / reference
https://scholar.google.com/scholar?q=Equisetum%20arvense%3A%20pharmacology%20and%20phytochemistry%20%E2%80%94%20a%20review - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - NatureSpot 'Marsh Horsetail - Equisetum palustre'. Available at: https://www.naturespot.org/species/marsh-horsetail Traditional / reference
https://www.naturespot.org/species/marsh-horsetail - Muller, J. and Puttich, P.M. and Beuerle, T (2020) 'Variation of the Main Alkaloid Content in Equisetum palustre L. in the Light of Its Ontogeny', Toxins, 12(11), pp. 710. doi:10.3390/toxins12110710 Preclinical
https://doi.org/10.3390/toxins12110710 - Ibi, A. and Du, M. and Beuerle, T. and Melchert, D. and Solnier, J. and Chang, C (2022) 'A Multi-Pronged Technique for Identifying Equisetum palustre and Equisetum arvense - Combining HPTLC, HPLC-ESI-MS/MS and Optimized DNA Barcoding Techniques', Plants, 11(19), pp. 2562. doi:10.3390/plants11192562 Preclinical
https://doi.org/10.3390/plants11192562
- Ng, Q.X., Venkatanarayanan, N. and Ho, C.Y.X (2017) 'Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis', Journal of Affective Disorders, 210, pp. 211-221. doi:10.1016/j.jad.2016.12.048 Meta-analysis / review
https://doi.org/10.1016/j.jad.2016.12.048 - Kholghi, G., Arjmandi-Rad, S., Zarrindast, M.R. and Vaseghi, S (2022) 'St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?', Naunyn-Schmiedeberg's Archives of Pharmacology, 395(6), pp. 629-642. doi:10.1007/s00210-022-02229-z Traditional / reference
https://doi.org/10.1007/s00210-022-02229-z - Fugh-Berman, A (2000) 'Herb-drug interactions', Lancet, 355(9198), pp. 134-138. doi:10.1016/S0140-6736(99)06457-0 Traditional / reference
https://doi.org/10.1016/S0140-6736(99)06457-0 - Nobakht, S.Z., Akaberi, M., Mohammadpour, A.H., Tafazoli Moghadam, A. and Emami, S.A (2022) 'Hypericum perforatum: Traditional uses, clinical trials, and drug interactions', Iranian Journal of Basic Medical Sciences, 25(9), pp. 1045-1058. doi:10.22038/IJBMS.2022.65112.14338 Meta-analysis / review
https://doi.org/10.22038/IJBMS.2022.65112.14338 - Jiang, Z., Wang, F., Zhao, Y., Lu, L., Jiang, X., Huang, T., Lin, Y., Guo, L., Weng, Z. and Liu, E (2024) 'Hypericum perforatum L. attenuates depression by regulating Akkermansia muciniphila, tryptophan metabolism and NFkB-NLRP2-Caspase1-IL1beta pathway', Phytomedicine, 132, pp. 155847. doi:10.1016/j.phymed.2024.155847 Preclinical
https://doi.org/10.1016/j.phymed.2024.155847 - Oliveira, A.I., Pinho, C., Sarmento, B. and Dias, A.C.P (2016) 'Neuroprotective Activity of Hypericum perforatum and Its Major Components', Frontiers in Plant Science, 7, pp. 1004. doi:10.3389/fpls.2016.01004 Meta-analysis / review
https://doi.org/10.3389/fpls.2016.01004 - Russo, E., Scicchitano, F., Whalley, B.J., Mazzitello, C., Ciriaco, M., Esposito, S., Patane, M., Upton, R., Pugliese, M., Chimirri, S., Mammi, M., Palleria, C. and De Sarro, G (2013) 'Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions', Phytotherapy Research, 28(5), pp. 643-655. doi:10.1002/ptr.5050 Meta-analysis / review
https://doi.org/10.1002/ptr.5050 - Saddiqe, Z., Naeem, I. and Maimoona, A (2010) 'A review of the antibacterial activity of Hypericum perforatum L', Journal of Ethnopharmacology, 131(3), pp. 511-521. doi:10.1016/j.jep.2010.07.034 Meta-analysis / review
https://doi.org/10.1016/j.jep.2010.07.034 - Mennini, T. and Gobbi, M (2004) 'The antidepressant mechanism of Hypericum perforatum', Life Sciences, 75(9), pp. 1021-1027. doi:10.1016/j.lfs.2004.04.005 Meta-analysis / review
https://doi.org/10.1016/j.lfs.2004.04.005 - Liu, Y., Jiang, Y., Huang, R., Yang, J., Xiao, B. and Dong, J (2013) 'Hypericum perforatum L. preparations for menopause: a meta-analysis of efficacy and safety', Climacteric, 17(4), pp. 325-335. doi:10.3109/13697137.2013.861814 Meta-analysis / review
https://doi.org/10.3109/13697137.2013.861814 - Wurglics, M. and Schubert-Zsilavecz, M (2006) 'Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients', Clinical Pharmacokinetics, 45(5), pp. 449-468. doi:10.2165/00003088-200645050-00002 Meta-analysis / review
https://doi.org/10.2165/00003088-200645050-00002 - Kasper, S (2001) 'Hypericum perforatum - a review of clinical studies', Pharmacopsychiatry, 34(Suppl 1), pp. S51-S55. doi:10.1055/s-2001-15467 Meta-analysis / review
https://doi.org/10.1055/s-2001-15467 - Nathan, P (1999) 'The experimental and clinical pharmacology of St John's Wort (Hypericum perforatum L.)', Molecular Psychiatry, 4(4), pp. 333-338. doi:10.1038/sj.mp.4000557 Meta-analysis / review
https://doi.org/10.1038/sj.mp.4000557 - Verotta, L (2003) 'Hypericum perforatum, a source of neuroactive lead structures', Current Topics in Medicinal Chemistry, 3(2), pp. 187-201. doi:10.2174/1568026033392589 Meta-analysis / review
https://doi.org/10.2174/1568026033392589 - Linde, K. et al (2008) 'St John'. Traditional / reference
https://scholar.google.com/scholar?q=St%20John - Natural Standard (2013) 'Hypericum perforatum (St'. Traditional / reference
https://scholar.google.com/scholar?q=Hypericum%20perforatum%20%28St - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Zhou, S., Chan, E., Pan, S.Q., Huang, M. and Lee, E.J.D (2004) 'Pharmacokinetic interactions of drugs with St John's wort', Journal of Psychopharmacology, 18(2), pp. 262-276. doi:10.1177/0269881104042632 Meta-analysis / review
https://doi.org/10.1177/0269881104042632 - Izzo, A.A. and Ernst, E (2009) 'Interactions between herbal medicines and prescribed drugs: an updated systematic review', Drugs, 69(13), pp. 1777-1798. doi:10.2165/11317010-000000000-00000 Meta-analysis / review
https://doi.org/10.2165/11317010-000000000-00000 - Borrelli, F. and Izzo, A.A (2009) 'Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations', The AAPS Journal, 11(4), pp. 710-727. doi:10.1208/s12248-009-9146-8 Meta-analysis / review
https://doi.org/10.1208/s12248-009-9146-8 - Nicolussi, S., Drewe, J., Butterweck, V. and Meyer zu Schwabedissen, H.E (2020) 'Clinical relevance of St. John's wort drug interactions revisited', British Journal of Pharmacology, 177(6), pp. 1212-1226. doi:10.1111/bph.14936 Meta-analysis / review
https://doi.org/10.1111/bph.14936 - Piscitelli, S.C., Burstein, A.H., Chaitt, D., Alfaro, R.M. and Falloon, J (2000) 'Indinavir concentrations and St John's wort', Lancet, 355(9203), pp. 547-548. doi:10.1016/S0140-6736(99)05712-8 Clinical study
https://doi.org/10.1016/S0140-6736(99)05712-8 - Barone, G.W., Gurley, B.J., Ketel, B.L., Lightfoot, M.L. and Abul-Ezz, S.R (2000) 'Drug interaction between St. John's wort and cyclosporine', Annals of Pharmacotherapy, 34(9), pp. 1013-1016. doi:10.1345/aph.10088 Clinical study
https://doi.org/10.1345/aph.10088 - Murphy, P.A., Kern, S.E., Stanczyk, F.Z. and Westhoff, C.L (2005) 'Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding', Contraception, 71(6), pp. 402-408. doi:10.1016/j.contraception.2004.11.004 Clinical study
https://doi.org/10.1016/j.contraception.2004.11.004 - Murphy, P.A., Kern, S.E., Stanczyk, F.Z. and Westhoff, C.L (2005) 'Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding', Contraception, 71(6), pp. 402-408. doi:10.1016/j.contraception.2004.11.004 Clinical study
https://doi.org/10.1016/j.contraception.2004.11.004 - Pfrunder, A., Schiesser, M., Gerber, S., Haschke, M., Bitzer, J. and Drewe, J (2003) 'Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial', British Journal of Clinical Pharmacology, 56(6), pp. 683-690. doi:10.1046/j.1365-2125.2003.02005.x Randomized trial
https://doi.org/10.1046/j.1365-2125.2003.02005.x - Johne, A., Brockmoller, J., Bauer, S., Maurer, A., Langheinrich, M. and Roots, I (1999) 'Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)', Clinical Pharmacology and Therapeutics, 66(4), pp. 338-345. doi:10.1053/cp.1999.v66.a101944 Clinical study
https://doi.org/10.1053/cp.1999.v66.a101944 - Mathijssen, R.H.J., Verweij, J., de Bruijn, P., Loos, W.J. and Sparreboom, A (2002) 'Effects of St. John's wort on irinotecan metabolism', Journal of the National Cancer Institute, 94(16), pp. 1247-1249. doi:10.1093/jnci/94.16.1247 Randomized trial
https://doi.org/10.1093/jnci/94.16.1247 - Smith, P., Bullock, J.M., Booker, B.M., Haas, C.E., Berenson, C.S. and Jusko, W.J (2004) 'The influence of St. John's wort on the pharmacokinetics and protein binding of imatinib mesylate', Pharmacotherapy, 24(11), pp. 1508-1514. doi:10.1592/phco.24.16.1508.50958 Clinical study
https://doi.org/10.1592/phco.24.16.1508.50958 - Izzo, A.A (2004) 'Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence', International Journal of Clinical Pharmacology and Therapeutics, 42(3), pp. 139-148. doi:10.5414/cpp42139 Meta-analysis / review
https://doi.org/10.5414/cpp42139 - Caus, M.N., Lupoae, M. and Chitescu, C.L (2026) 'Efficacy and Safety of Herbal Supplements with Anxiolytic, Antidepressant, and Sedative Action: A Review of Clinical Data and Toxicological Risks', Pharmaceuticals, 19(3), pp. 399. doi:10.3390/ph19030399 Meta-analysis / review
https://doi.org/10.3390/ph19030399
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.